Abaloparatide is a parathyroid hormone-related protein (PTHrP) analog drug in clinical development for treating osteoporosis. Like the related drug teriparatide, and unlike bisphosphonates, it is an anabolic (i.e., bone growing) agent.
CAT No: 10-101-172
CAS No:247062-33-5
Synonyms/Alias:Abaloparatide;247062-33-5;Abaloparatide acetate;XJA06233;H-DL-Ala-DL-Val-DL-Ser-DL-Glu-DL-His-DL-Gln-DL-Leu-DL-Leu-DL-His-DL-Asp-DL-Lys-Gly-DL-Lys-DL-Ser-DL-xiIle-DL-Gln-DL-Asp-DL-Leu-DL-Arg-DL-Arg-DL-Arg-DL-Glu-DL-Leu-DL-Leu-DL-Glu-DL-Lys-DL-Leu-DL-Leu-Aib-DL-Lys-DL-Leu-DL-His-DL-xiThr-DL-Ala-NH2;
Abaloparatide, a synthetic analog of human parathyroid hormone-related peptide (PTHrP), is a cutting-edge peptide compound widely recognized for its unique ability to modulate bone metabolism. As a research-grade peptide, Abaloparatide demonstrates high sequence fidelity to its native counterpart, enabling precise mimicry of physiological signaling pathways. Its robust stability and solubility in aqueous solutions make it an attractive molecule for in vitro studies, mechanistic explorations, and advanced pharmaceutical research. Researchers value its selective activation of the parathyroid hormone 1 receptor (PTH1R), which initiates downstream signaling cascades pivotal to bone remodeling and mineral homeostasis. The versatility and specificity of Abaloparatide have positioned it as an essential tool in the investigation of skeletal biology, peptide-receptor interactions, and the development of next-generation peptide therapeutics.
Bone Formation Mechanisms: Abaloparatide is extensively utilized in studies examining the stimulation of osteoblast activity and bone matrix synthesis. By selectively binding to PTH1R, it activates intracellular cAMP pathways, leading to the upregulation of genes associated with bone formation. This mechanism allows researchers to dissect the molecular events underlying anabolic bone processes, offering valuable insights into skeletal tissue engineering and the potential for novel bone regenerative strategies. Its application in three-dimensional cell culture models and organoid systems further enhances the understanding of bone physiology and the dynamic interplay between bone-forming cells and their microenvironment.
Osteoclast Regulation and Bone Resorption: Investigators employ this peptide to elucidate its effects on osteoclast differentiation and function. Through indirect modulation of osteoclastogenesis, Abaloparatide provides a platform to study the balance between bone formation and resorption. Researchers can assess changes in osteoclast marker expression, cellular activity, and the impact on bone microarchitecture using advanced imaging and biochemical assays. These studies are integral to unraveling the complexities of bone turnover and developing targeted interventions for skeletal disorders characterized by excessive bone loss.
Peptide-Receptor Binding Studies: The high affinity and selectivity of Abaloparatide for PTH1R make it an ideal model for receptor-ligand interaction research. Scientists utilize various biophysical and structural biology techniques, such as surface plasmon resonance, nuclear magnetic resonance, and crystallography, to characterize the binding kinetics and conformational changes induced by the peptide. These investigations contribute to a deeper understanding of receptor activation mechanisms, informing the rational design of improved peptide therapeutics with enhanced efficacy and specificity.
Signal Transduction Pathway Analysis: Abaloparatide serves as a valuable probe for mapping intracellular signaling networks triggered by PTH1R activation. By monitoring downstream effectors such as protein kinase A (PKA), CREB phosphorylation, and gene transcription profiles, researchers can delineate the cascade of molecular events following peptide stimulation. Such studies enable the identification of novel signaling nodes and regulatory checkpoints, facilitating the development of new strategies to modulate bone metabolism at the cellular and molecular levels.
Pharmaceutical Development and Drug Screening: The unique pharmacological profile of this peptide has inspired its adoption in preclinical drug discovery platforms. Abaloparatide is incorporated into high-throughput screening assays to evaluate compound libraries for potential modulators of bone anabolic pathways. Its application in pharmacodynamic studies, in vitro efficacy testing, and structure-activity relationship analyses accelerates the identification and optimization of candidate molecules for bone-related research. By serving as a reference compound, it also aids in benchmarking the performance of novel peptide analogs and small-molecule agonists.
In summary, Abaloparatide's multifaceted applications span fundamental bone biology research, peptide-receptor interaction studies, and pharmaceutical development. Its ability to selectively activate PTH1R and modulate key signaling pathways makes it indispensable for elucidating the mechanisms of bone metabolism and supporting the advancement of innovative therapeutic strategies. As research continues to evolve, the peptide's contributions to understanding skeletal homeostasis and peptide-based drug design are poised to expand, further solidifying its role as a cornerstone in the field of bone and mineral research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More